Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model

Journal of Medical Microbiology

Volumn 53, Issue 6, 2004, Pages 495-500

  Takakura, Natsuko ^a,b   Wakabayashi, Hiroyuki ^a   Ishibashi, Hiroko ^b   Yamauchi, Koji ^a   Teraguchi, Susumu ^a   Tamura, Yoshitaka ^a   Yamaguchi, Hideyo ^b   Abe, Shigeru ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; LACTOFERRIN; PREDNISOLONE;

ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CANDIDA; CANDIDIASIS; CATTLE; CELL STIMULATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG EFFECT; EXPERIMENTAL MODEL; FEEDING; HEATING; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CELLS, CULTURED; CONCANAVALIN A; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOCOMPROMISED HOST; LACTOFERRIN; LEUKOCYTE COUNT; LEUKOCYTES; LYMPH NODES; MICE; MICE, INBRED ICR; MOUTH MUCOSA; PREDNISOLONE; TIME FACTORS;

EID: 3042664560     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05505-0     Document Type: Article

References (34)

1. Abe, S., Okutomi, T., Tansho, S., Ishibashi, H., Wakabayashi, H., Teraguchi, S., Hayasawa, H. & Yamaguchi, H. (2000). Augmentation by lactoferrin of host defense against Candida infection in mice. In Lactoferrin: Structure, Function and Applications, pp. 195-201. Edited by K. Shimazaki, H. Tsuda, M. Tomita, T. Kuwata & J.-P. Perraudin. Amsterdam: Elsevier.
2. Akagawa, G., Abe, S. & Yamaguchi, H. (1995). Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J Infect Dis 171, 1539-1544.
3. Artym, J., Zimecki, M. & Kruzel, M. L. (2003). Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Immunobiology 207, 197-205.
4. Bhimani, R. S., Vendrov, Y. & Furmanski, P. (1999). Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol 86, 135-144.
5. Brock, J. (1995). Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 16, 417-419.
6. Elahi, S., Pang, G., Clancy, R. & Ashman, R. B. (2000). Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect Immun 68, 5771-5777.
7. Farah, C. S., Elahi, S., Pang, G., Gotjamanos, T., Seymour, G. J., Clancy, R. L. & Ashman, R. B. (2001). T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect Immun 69, 6110-6118.
8. Farah, C. S., Gotjamanos, T., Seymour, G. J. & Ashman, R. B. (2002). Cytokines in the oral mucosa of mice infected with Candida albicans. Oral Microbiol Immunol 17, 375-378.
9. Fidel, P. L., Jr (2002). Immunity to Candida. Oral Dis 8 (Suppl. 2), 69-75.
10. Haversen, L. A., Engberg, I., Baltzer, L, Dolphin, G., Hanson, L. A. & Mattsby-Baltzer, I. (2000). Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 68, 5816-5823.
11. Hermann, P., Berek, Z., Nagy, G., Kamotsay, K. & Rozgonyi, F. (2001). Pathogenesis, microbiological and clinical aspects of oral candidiasis (candidosis). Acta Microbiol Immunol Hung 48, 479-495.
12. Ishii, K., Takamura, N., Shinohara, M., Wakui, N., Shin, H., Sumino, Y., Ohmoto, Y., Teraguchi, S. & Yamauchi, K. (2003). Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol Res 25, 226-233.
13. Iwasa, M., Kaito, M., Ikoma, J., Takeo, M., Imoto, I., Adachi, Y., Yamauchi, K., Koizumi, R. & Teraguchi, S. (2002). Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype Ib. Am J Gastroenterol 97, 766-767.
14. Kuhara, T., Iigo, M., Itoh, T., Ushida, Y., Sekine, K., Terada, N., Okamura, H. & Tsuda, H. (2000). Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr Cancer 38, 192-199.
15. Kuipers, M. E., de Vries, H. G., Eikelboom, M. C., Meijer, D. K. & Swart, P. J. (1999). Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother 43, 2635-2641.
16. Lopez-Ribot, J. L., McAtee, R. K., Perea, S., Kirkpatrick, W. R., Rinaldi, M. G. & Patterson, T. F. (1999). Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 43, 1621-1630,
17. Maebashi, K., Itoyama, T., Uchida, K., Suegara, N. & Yamaguchi, H. (1994). A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs. J Med Vet Mycol 32, 349-359.
18. Masci, J. R. (2000). Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme. AIDS 14, 2403-2404.
19. Sekine, K., Ushida, Y., Kuhara, T. & 8 other authors (1997). Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett 121, 211-216.
20. Takakura, N., Sato, Y., Ishibashi, H., Oshima, H., Uchida, K., Yamaguchi, H. & Abe, S. (2003a). A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol 47, 321-326.
21. Takakura, N., Wakabayashi, H., Ishibashi, H., Teraguchi, S., Tamura, Y., Yamaguchi, H. & Abe, S. (2003b). Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob Agents Chemother 47, 2619-2623.
22. Tansho, S., Abe, S. & Yamaguchi, H. (1994). Inhibition of Candida albicans growth by murine peritoneal neutrophils and augmentation of the inhibitory activity by bacterial lipopolysaccharide and cytokines. Microbiol Immunol 38, 379-383.
23. Teraguchi, S., Shin, K., Ozawa, K., Nakamura, S., Fukuwatari, Y., Tsuyuki, S., Namihira, H. & Shimamura, S. (1995). Bacteriostatic effect of orally administered bovine lactoferrin on proliferation of Clostridium species in the gut of mice fed bovine milk. Appl Environ Microbiol 61, 501-506.
24. Tomita, M., Wakabayashi, H., Yamauchi, K., Teraguchi, S. & Hayasawa, H. (2002). Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem Cell Biol 80, 109-112.
25. Trinchieri, G., Kubin, M., Bellone, G. & Cassatella, M. A. (1993). Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. J Cell Biochem 53, 301-308.
26. Vorland, L. H. (1999). Lactoferrin: a multifunctional glycoprotein. APMIS 107, 971-981.
27. Wada, T., Aiba, Y., Shimizu, K., Takagi, A., Miwa, T. & Koga, Y. (1999). The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori. Scand J Gastroenterol 34, 238-243.
28. Wakabayashi, H., Abe, S., Okutomi, T., Tansho, S., Kawase, K. & Yamaguchi, H. (1986). Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol Immunol 40, 821-825.
29. Wakabayashi, H., Abe, S., Teraguchi, S., Hayasawa, H. & Yamaguchi, H. (1898). Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother 42, 1587-1591.
30. Wakabayashi, H., Uchida, K., Yamauchi, K., Teraguchi, S., Hayasawa, H. & Yamaguchi, H. (2000). Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. J Antimicrob Chemother 46, 595-602.
31. Wakabayashi, H., Takakura, N., Yamauchi, K., Teraguchi, S., Uchida, K., Yamaguchi, H. & Tamura, Y. (2002). Effect of lactoferrin feeding on the host antifungal response in guinea-pigs infected or immunised with Trichophyton mentagrophytes. J Med Microbiol 51, 844-850.
32. Wakabayashi, H., Takakura, N., Teraguchi, S. & Tamura, Y. (2003). Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol Immunol 47, 37-43.
33. Walsh, T. J., Gonzalez, C. E., Piscitelli, S. & 7 other authors (2000). Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. J Clin Microbiol 38, 2369-2373.
34. Yamauchi, K., Hiruma, M., Yamazaki, N., Wakabayashi, H., Kuwata, H., Teraguchi, S., Hayasawa, H., Suegara, N. & Yamaguchi, H. (2000). Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study. Mycoses 43, 197-202.